GARDNER JASON

DNTH

GARDNER JASON serves as See Remarks at Dianthus Therapeutics, Inc. (DNTH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$96.5K

Net Position

Net Seller

$96.5K

Companies Traded

DNTH

Active Period

Sep 2021

1 total trades

Most Recent

Sell DNTH

Sep 20, 2021 · $96.5K

GARDNER JASON's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

0 · $0.00

Sells

1 · $96.5K

Total Shares Bought

Total Shares Sold

14,340

DNTH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 20, 2021	Sell	14,340	$6.73	$96.5K	286,872

Related Insiders

CARR EDWARD

officer: CHIEF ACCOUNTING OFFICER

DNTHSell · Mar 13, 2026

Marino Garcia

director, officer: CEO AND PRESIDENT

DNTHSell · Mar 13, 2026

Simrat Randhawa

officer: EVP, Head of R&D

DNTHSell · Mar 13, 2026

Ryan Savitz

CFO & CBO

DNTHSell · Dec 4, 2025

Explore More Insider Trading Data

DNTH Insider Trading Activity

View all insider trades at Dianthus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity